Health-system Pharmacy Research Articles

Actions of the ASHP Board of Directors - Meeting of September 15-16, 2022.

Journal Article Corrected proof Actions of the ASHP Board of Directors — Meeting of September 15-16, 2022 Get access American Journal of Health-System Pharmacy, zxad054, https://doi.org/10.1093/ajhp/zxad054 Published: 27 March 2023

Elacestrant Dihydrochloride.

Journal Article Corrected proof Elacestrant Dihydrochloride Get access American Journal of Health-System Pharmacy, zxad050, https://doi.org/10.1093/ajhp/zxad050 Published: 24 March 2023

Establishing a Workload Productivity Target in an Outpatient Infusion Pharmacy

Health-system pharmacies are under increasing pressure to maximize resources and improve efficiency, as the cost of healthcare is rising and reimbursement for medications is becoming increasingly complex. One strategy for optimizing efficiency is to utilize workforce productivity metrics to ensure the optimal staffing. While there have been many published examples of productivity-tracking models for health-system pharmacies in general, there are gaps in the literature on outpatient infusion pharmacy productivity metrics, as these pharmacies have unique workflow patterns and considerations. This paper describes some of those special considerations for infusion pharmacies and proposes a potential method for tracking workload productivity in a way that addresses those special factors. Also discussed are the limitations of this method, as well as areas for future exploration in tracking productivity in an infusion pharmacy.

Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights, October-December 2022.

Journal Article Summaries of Safety Labeling Changes Approved By FDA—Boxed Warnings Highlights, October–December 2022 Get access American Journal of Health-System Pharmacy, Volume 80, Issue 6, 15 March 2023, Page 330, https://doi.org/10.1093/ajhp/zxad014 Published: 07 March 2023 Article history Corrected and typeset: 07 March 2023 Published: 07 March 2023

Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights, October-December 2022.

Journal Article Summaries of Safety Labeling Changes Approved By FDA—Boxed Warnings Highlights, October–December 2022 Get access American Journal of Health-System Pharmacy, Volume 80, Issue 6, 15 March 2023, Pages e74–e75, https://doi.org/10.1093/ajhp/zxad015 Published: 07 March 2023 Article history Corrected and typeset: 07 March 2023 Published: 07 March 2023

Fecal microbiota, live-jslm.

Journal Article Corrected proof Fecal microbiota, live-jslm Get access American Journal of Health-System Pharmacy, zxad032, https://doi.org/10.1093/ajhp/zxad032 Published: 27 February 2023 Article history Corrected and typeset: 27 February 2023 Published: 27 February 2023

Actions of the ASHP Board of Directors - Meeting of June 11 and 14, 2022.

Journal Article Corrected proof Actions of the ASHP Board of Directors — Meeting of June 11 and 14, 2022 Get access American Journal of Health-System Pharmacy, zxad028, https://doi.org/10.1093/ajhp/zxad028 Published: 27 February 2023 Article history Corrected and typeset: 27 February 2023 Published: 27 February 2023

Lecanemab-irmb.

Journal Article Corrected proof Lecanemab-irmb Get access American Journal of Health-System Pharmacy, zxad033, https://doi.org/10.1093/ajhp/zxad033 Published: 27 February 2023 Article history Corrected and typeset: 27 February 2023 Published: 27 February 2023

Anacaulase-bcdb.

Journal Article Corrected proof Anacaulase-bcdb Get access American Journal of Health-System Pharmacy, zxad031, https://doi.org/10.1093/ajhp/zxad031 Published: 27 February 2023 Article history Corrected and typeset: 27 February 2023 Published: 27 February 2023

Ublituximab-xiiy.

Journal Article Corrected proof Ublituximab-xiiy Get access American Journal of Health-System Pharmacy, zxad034, https://doi.org/10.1093/ajhp/zxad034 Published: 27 February 2023

Adagrasib.

Journal Article Corrected proof Adagrasib Get access American Journal of Health-System Pharmacy, zxad016, https://doi.org/10.1093/ajhp/zxad016 Published: 27 February 2023 Article history Corrected and typeset: 27 February 2023 Published: 27 February 2023

Mirvetuximab Soravtansine-gynx.

Journal Article Mirvetuximab Soravtansine-gynx Get access American Journal of Health-System Pharmacy, Volume 80, Issue 7, 1 April 2023, Pages 395–397, https://doi.org/10.1093/ajhp/zxad001 Published: 21 February 2023 Article history Corrected and typeset: 21 February 2023 Published: 21 February 2023

Actions of the ASHP Board of Directors - Meeting of April 7-8, 2022.

Journal Article Corrected proof Actions of the ASHP Board of Directors — Meeting of April 7-8, 2022 Get access American Journal of Health-System Pharmacy, zxad027, https://doi.org/10.1093/ajhp/zxad027 Published: 18 February 2023 Article history Corrected and typeset: 18 February 2023 Published: 18 February 2023

Mosunetuzumab-axgb.

Journal Article Corrected proof Mosunetuzumab-axgb Get access American Journal of Health-System Pharmacy, zxad019, https://doi.org/10.1093/ajhp/zxad019 Published: 18 February 2023 Article history Corrected and typeset: 18 February 2023 Published: 18 February 2023

Lenacapavir Sodium.

Journal Article Corrected proof Lenacapavir Sodium Get access American Journal of Health-System Pharmacy, zxad018, https://doi.org/10.1093/ajhp/zxad018 Published: 18 February 2023 Article history Corrected and typeset: 18 February 2023 Published: 18 February 2023

Actions of the ASHP Board of Directors - Meeting of January 20-21, 2022.

Journal Article Corrected proof Actions of the ASHP Board of Directors — Meeting of January 20-21, 2022 Get access American Journal of Health-System Pharmacy, zxad026, https://doi.org/10.1093/ajhp/zxad026 Published: 18 February 2023 Article history Corrected and typeset: 18 February 2023 Published: 18 February 2023

Provision of Patient Care Services and Goals for Expansion in Community and Ambulatory Care Pharmacies in Southeastern North Carolina.

In February 2022, the North Carolina legislature expanded pharmacist dispensing authority without a prescription. We conducted a cross-sectional interview of currently licensed pharmacy managers of outpatient pharmacies located in five counties in southeastern North Carolina. Pharmacy managers were eligible to participate if their pharmacy was either a community pharmacy, clinic-based pharmacy, or outpatient health system pharmacy. Forty-four of 116 eligible pharmacy managers participated (38% response rate). The most common services offered by pharmacies included medication synchronization services (93.2%), on-site immunizations (90.9%), and refill reminders (88.6%). The least common services offered include INR screens (0%), A1c screens (7%), and 'incident-to' billing services associated with CPT codes: annual wellness visits (0%), chronic care management (0%), transitional care management (0%), and remote patient monitoring (2.4%). The services that pharmacy managers wanted to learn more about through continuing education included: oral/transdermal contraceptives (60.5%), administration of long-acting injectables (LAIs) (36.8%), and dispensing of HIV post-exposure prophylaxis (PEP) (23.7%).

News briefs.

Journal Article News briefs Get access American Journal of Health-System Pharmacy, Volume 80, Issue 4, 15 February 2023, Page 173, https://doi.org/10.1093/ajhp/zxad013 Published: 15 February 2023 Article history Corrected and typeset: 15 February 2023 Published: 15 February 2023

Teplizumab-mzwv.

Journal Article Teplizumab-mzwv Get access American Journal of Health-System Pharmacy, Volume 80, Issue 7, 1 April 2023, Pages 401–403, https://doi.org/10.1093/ajhp/zxad003 Published: 13 February 2023 Article history Corrected and typeset: 13 February 2023 Published: 13 February 2023

Olutasidenib.

Journal Article Corrected proof Olutasidenib American Journal of Health-System Pharmacy, zxad002, https://doi.org/10.1093/ajhp/zxad002 Published: 13 February 2023